BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash & Current Investments data on file, last reported at $20.1 billion in Q4 2025.

• In Q4 2025, Cash & Current Investments rose 12.25% year-over-year to $20.1 billion; the TTM figure through Dec 2025 stood at $20.1 billion (up 12.25% YoY), while the FY2025 annual figure was $19.5 billion, up 8.95% from the prior year.
• Cash & Current Investments rose to $20.1 billion in Q4 2025, from $17.0 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $1459786.9 billion in Q1 2021 and bottomed at $1.4 billion in Q3 2021.
• A 5-year average of $73096.8 billion and a median of $16.8 billion in 2023 frame the typical range for Cash & Current Investments.
• The widest YoY moves for Cash & Current Investments: up 563.22% in 2022, down 99.87% in 2022.
• Year by year, Cash & Current Investments stood at $2.4 billion in 2021, then jumped by 504.7% to $14.3 billion in 2022, then rose by 24.09% to $17.8 billion in 2023, then climbed by 0.73% to $17.9 billion in 2024, then climbed by 12.25% to $20.1 billion in 2025.
• The last three Cash & Current Investments figures came in at $20.1 billion (Q4 2025), $17.0 billion (Q3 2025), and $15.9 billion (Q2 2025), per Business Quant data.

Peer Comparison